Non-specific intracellular chelating sites

Non-specific intracellular chelating sites refer to a diverse collection of endogenous molecules, including proteins like metallothioneins and small molecules like glutathione, that possess the ability to bind metal ions within the cell (NCBI, PMC3542354). These sites play a critical role in maintaining metal ion homeostasis and protecting cellular components from oxidative stress and heavy metal toxicity by sequestering reactive or surplus ions (StatPearls, NBK541080). In a pharmacological context, these sites are often viewed as "sinks" that can interfere with the distribution and efficacy of metal-based drugs or chelating therapies. For instance, the binding of platinum-based chemotherapeutics to these non-specific sites can contribute to drug resistance and systemic toxicity. Conversely, therapeutic chelating agents are designed to outcompete these endogenous sites to mobilize and remove toxic metals from the body (PubChem, CID 2973). Understanding the capacity and affinity of these sites is essential for predicting the toxicokinetic profile of various metal-containing compounds and chelators. Because this term describes a functional category rather than a single discrete protein, it is primarily used to describe the cellular environment's interaction with metal ions.

Other names

Intracellular metal-binding sitesEndogenous metal sinksNon-specific metal sequestration sitesIntracellular metal chelators

Chelating agents compete with these endogenous sites to bind and mobilize metal ions for excretion, while certain metal-based drugs may be sequestered by these sites, affecting their bioavailability and toxicity (StatPearls, 2023; NCBI, PMC3542354).